{"id":44991,"date":"2022-06-13T12:01:33","date_gmt":"2022-06-13T10:01:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/"},"modified":"2022-06-13T12:01:33","modified_gmt":"2022-06-13T10:01:33","slug":"global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/","title":{"rendered":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2367212\/global_ophthalmics_partnering_20142022_deal?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cngvz7&amp;utm_campaign=1712492+-+Global+Ophthalmics+Partnering+Analysis+Report+2014-2022%3A+Trends%2C+Players+and+Financials+for+550%2B+Deals&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Ophthalmics Partnering 2014-2022 report provides comprehensive access to available deals and contract documents for over 550 ophthalmics deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2014.\n<\/p>\n<ul>\n<li>\nTrends in Ophthalmics partnering deals\n<\/li>\n<li>\nFinancial deal terms for headline, upfront and royalty by stage of development\n<\/li>\n<li>\nOphthalmics partnering agreement structure\n<\/li>\n<li>\nOphthalmics partnering contract documents\n<\/li>\n<li>\nTop Ophthalmics deals by value\n<\/li>\n<li>\nMost active Ophthalmics dealmakers\n<\/li>\n<\/ul>\n<p>\nMost of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor&#8217;s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&amp;D and a commercialization of outcomes element.\n<\/p>\n<p>\nThe report takes readers through the comprehensive Ophthalmics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Ophthalmics deals.\n<\/p>\n<p>\nThe report presents financial deal terms values for Ophthalmics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.\n<\/p>\n<p>\nThe initial chapters of this report provide an orientation of Ophthalmics dealmaking trends.\n<\/p>\n<p>\nChapter 2 provides an overview of the trends in Ophthalmics dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.\n<\/p>\n<p>\nChapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.\n<\/p>\n<p>\nChapter 4 provides a review of the leading Ophthalmics deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Ophthalmics dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.\n<\/p>\n<p>\nChapter 5 provides comprehensive access to Ophthalmics deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nChapter 6 provides a comprehensive directory of all Ophthalmics partnering deals by specific Ophthalmics target announced since 2014. The chapter is organized by specific Ophthalmics therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nIn addition, a comprehensive appendix is provided with each report of all Ophthalmics partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&amp;D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nThe report also includes numerous tables and figures that illustrate the trends and activities in Ophthalmics partnering and dealmaking since 2014.\n<\/p>\n<p>\nIn conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Ophthalmics technologies and products.\n<\/p>\n<p>\nThe report includes deals for the following indications: Age-related macular degeneration, Blindness, Cataracts, Conjunctivitis, Diabetic macular edema, Dry eye, Glaucoma, Ocular hypertension, Retinal detachment Retinopathy, Diabetic retinopathy, Uveitis, plus other ophthalmic indications.\n<\/p>\n<p>\n<strong>Report scope<\/strong>\n<\/p>\n<p>\n<strong>Global Ophthalmics Partnering 2014 to 2022 includes:<\/strong>\n<\/p>\n<ul>\n<li>\nTrends in Ophthalmics dealmaking in the biopharma industry since 2014\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nAccess to hundreds of Ophthalmics deal contract documents\n<\/li>\n<li>\nComprehensive access to over 700 Ophthalmics deal records\n<\/li>\n<li>\nThe leading Ophthalmics deals by value since 2014\n<\/li>\n<li>\nMost active Ophthalmics dealmakers since 2014\n<\/li>\n<\/ul>\n<p>\n<strong>In Global Ophthalmics Partnering 2014 to 2022, available deals and contracts are listed by:<\/strong>\n<\/p>\n<ul>\n<li>\nHeadline value\n<\/li>\n<li>\nUpfront payment value\n<\/li>\n<li>\nRoyalty rate value\n<\/li>\n<li>\nStage of development at signing\n<\/li>\n<li>\nDeal component type\n<\/li>\n<li>\nTechnology type\n<\/li>\n<li>\nSpecific therapy indication\n<\/li>\n<\/ul>\n<p>\n<strong>Analyzing actual contract agreements allows assessment of the following:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?\n<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?\n<\/li>\n<li>\nWhat exclusivity is granted?\n<\/li>\n<li>\nWhat is the payment structure for the deal?\n<\/li>\n<li>\nHow are the sales and payments audited?\n<\/li>\n<li>\nWhat is the deal term?\n<\/li>\n<li>\nHow are the key terms of the agreement defined?\n<\/li>\n<li>\nHow are IPRs handled and owned?\n<\/li>\n<li>\nWho is responsible for commercialization?\n<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?\n<\/li>\n<li>\nHow is confidentiality and publication managed?\n<\/li>\n<li>\nHow are disputes to be resolved?\n<\/li>\n<li>\nUnder what conditions can the deal be terminated?\n<\/li>\n<li>\nWhat happens when there is a change of ownership?\n<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?\n<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?\n<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\n<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in Ophthalmics dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Ophthalmics partnering over the years\n<\/p>\n<p>\n2.3. Ophthalmics partnering by deal type\n<\/p>\n<p>\n2.4. Ophthalmics partnering by industry sector\n<\/p>\n<p>\n2.5. Ophthalmics partnering by stage of development\n<\/p>\n<p>\n2.6. Ophthalmics partnering by technology type\n<\/p>\n<p>\n2.7. Ophthalmics partnering by therapeutic indication\n<\/p>\n<p>\n<strong>Chapter 3 -Financial deal terms for Ophthalmics partnering<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Disclosed financials terms for Ophthalmics partnering\n<\/p>\n<p>\n3.3. Ophthalmics partnering headline values\n<\/p>\n<p>\n3.4. Ophthalmics deal upfront payments\n<\/p>\n<p>\n3.5. Ophthalmics deal milestone payments\n<\/p>\n<p>\n3.6. Ophthalmics royalty rates\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Leading Ophthalmics deals and dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active in Ophthalmics partnering\n<\/p>\n<p>\n4.3. List of most active dealmakers in Ophthalmics\n<\/p>\n<p>\n4.4. Top Ophthalmics deals by value\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Ophthalmics contract document directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Ophthalmics partnering deals where contract document available\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Ophthalmics dealmaking by therapeutic target<\/strong>\n<\/p>\n<p>\n6.1. Introduction\n<\/p>\n<p>\n6.2. Deals by Ophthalmics therapeutic target\n<\/p>\n<p>\n<strong>Appendices<\/strong>\n<\/p>\n<p>\nAppendix 1 &#8211; Directory of Ophthalmics deals by company A-Z 2014 to 2022\n<\/p>\n<p>\nAppendix 2 &#8211; Directory of Ophthalmics deals by deal type 2014 to 2022\n<\/p>\n<p>\nAppendix 3 &#8211; Directory of Ophthalmics deals by stage of development 2014 to 2022\n<\/p>\n<p>\nAppendix 4 &#8211; Directory of Ophthalmics deals by technology type 2014 to 2022\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nBiohealth Innovation\n<\/li>\n<li>\nBrigham and Women&#8217;s Hospital\n<\/li>\n<li>\nAlnylam Pharmaceuticals\n<\/li>\n<li>\nEastman Chemical Company\n<\/li>\n<li>\nApexian Pharmaceuticals\n<\/li>\n<li>\nPing An Ventures\n<\/li>\n<li>\nEversana\n<\/li>\n<li>\nNarayana Nethralaya Foundation\n<\/li>\n<li>\nBLP Management\n<\/li>\n<li>\nFood and Drug Administration (FDA)\n<\/li>\n<li>\nCovenant Surgical Partners\n<\/li>\n<li>\nGHO Capital\n<\/li>\n<li>\nSBI Capital Markets\n<\/li>\n<li>\nNevakar\n<\/li>\n<li>\nGlenmark Pharmaceuticals\n<\/li>\n<li>\nEwopharma\n<\/li>\n<li>\nKC Pharmaceuticals\n<\/li>\n<li>\nLV Prasad Eye Institute\n<\/li>\n<li>\nCerevast Therapeutics\n<\/li>\n<li>\nFoundation Fighting Blindness\n<\/li>\n<li>\nSimulations Plus\n<\/li>\n<li>\nLaboratoires Thea\n<\/li>\n<li>\nLambdaVision\n<\/li>\n<li>\nBluejay Diagnostics\n<\/li>\n<li>\nNovaBay Pharmaceuticals\n<\/li>\n<li>\nEvergaze\n<\/li>\n<li>\nColumbia Technology Ventures\n<\/li>\n<li>\nColumbia University\n<\/li>\n<li>\nCannabics Pharmaceuticals\n<\/li>\n<li>\nAker BioMarine\n<\/li>\n<li>\nAura Biosciences\n<\/li>\n<li>\nAXIM Biotechnologies\n<\/li>\n<li>\nMitsubishi Tanabe Pharma\n<\/li>\n<li>\nTangible Science\n<\/li>\n<li>\nThromboGenics\n<\/li>\n<li>\nAndrec\n<\/li>\n<li>\nEvotec\n<\/li>\n<li>\nIveric Bio\n<\/li>\n<li>\nNordic Prime\n<\/li>\n<li>\nBionic Sight\n<\/li>\n<li>\nIconic Therapeutics\n<\/li>\n<li>\nArctic Vision\n<\/li>\n<li>\nCyclica\n<\/li>\n<li>\nAmerican Academy of Ophthalmology\n<\/li>\n<li>\nKali Care\n<\/li>\n<li>\nCell Care Therapeutics\n<\/li>\n<li>\nArcticDx\n<\/li>\n<li>\nWallace H. Coulter Foundation\n<\/li>\n<li>\nAdvanced Dosage Forms\n<\/li>\n<li>\nAOAExcel\n<\/li>\n<li>\nChangchun High &amp; New Technology Industries\n<\/li>\n<li>\nMassachusetts Eye and Ear Infirmary\n<\/li>\n<li>\nMassachusetts General Hospital\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2367212\/global_ophthalmics_partnering_20142022_deal?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cngvz7&amp;utm_campaign=1712492+-+Global+Ophthalmics+Partnering+Analysis+Report+2014-2022%3A+Trends%2C+Players+and+Financials+for+550%2B+Deals&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/sprmg7<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#112;&#x72;&#101;&#x73;&#115;&#x40;r&#x65;s&#101;&#x61;&#114;&#x63;h&#x61;n&#x64;&#x6d;&#97;&#x72;&#107;&#x65;t&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#x65;s&#115;&#x40;r&#101;&#x73;e&#97;&#x72;c&#104;&#x61;&#x6e;&#100;&#x6d;&#x61;r&#107;&#x65;t&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Ophthalmics Partnering 2014-2022 report provides comprehensive access to available deals and contract documents for over 550 ophthalmics deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-44991","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Ophthalmics Partnering 2014-2022 report provides comprehensive access to available deals and contract documents for over 550 ophthalmics deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-13T10:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-13T10:01:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/\"},\"wordCount\":1169,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005432\\\/en\\\/1484240\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/\",\"name\":\"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005432\\\/en\\\/1484240\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-13T10:01:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005432\\\/en\\\/1484240\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005432\\\/en\\\/1484240\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Ophthalmics Partnering 2014-2022 report provides comprehensive access to available deals and contract documents for over 550 ophthalmics deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-13T10:01:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals &#8211; ResearchAndMarkets.com","datePublished":"2022-06-13T10:01:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/"},"wordCount":1169,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/","name":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg","datePublished":"2022-06-13T10:01:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220613005432\/en\/1484240\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-ophthalmics-partnering-analysis-report-2014-2022-trends-players-and-financials-for-550-deals-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44991"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44991\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}